| Literature DB >> 29797809 |
Renuka S Bindraban1,2, Maarten J Ten Berg1, Christiana A Naaktgeboren1,3, Mark H H Kramer2, Wouter W Van Solinge1, Prabath W B Nanayakkara4.
Abstract
BACKGROUND: Studies addressing the appropriateness of laboratory testing have revealed approximately 20% overutilization. We conducted a narrative review to (1) describe current interventions aimed at reducing unnecessary laboratory testing, specifically in hospital settings, and (2) provide estimates of their efficacy in reducing test order volume and improving patient-related clinical outcomes.Entities:
Keywords: Intervention; Laboratory testing; Laboratory utilization; Reduction; Unnecessary laboratory testing; Unnecessary laboratory utilization
Mesh:
Year: 2018 PMID: 29797809 PMCID: PMC5973913 DOI: 10.3343/alm.2018.38.5.402
Source DB: PubMed Journal: Ann Lab Med ISSN: 2234-3806 Impact factor: 3.464
Fig. 1Flowchart of the literature search algorithm used for identifying and selecting studies for inclusion in this review.
Abbrevations: CADTH HTA, Canadian Agency for Drugs and Technologies in Health-Health Technology Assessment.
Characteristics of included studies
| N (%) | |
|---|---|
| Study design | |
| Before after study | 56.6 (66.7) |
| Retrospective audit | 8 (9.5) |
| Randomized controlled trial | 5 (6.0) |
| Non-randomized controlled trial | 15 (17.8) |
| Similarity of patients and providers between comparison groups | |
| Both patients and providers comparable between both groups | 7 (8.3) |
| Patients comparable, providers not comparable | 1 (1.2) |
| Patients and providers not comparable | 1 (1.2) |
| Patients comparable, no data on comparability of providers | 21 (25.0) |
| Patients not comparable, no data on comparability of providers | 3 (3.6) |
| Providers comparable, no data on comparability of patients | 7 (8.3) |
| No data on comparability of either patients or providers | 36 (42.9) |
| No comparator group | 8 (9.5) |
| Number of centers included | 78 (92.9) |
| Single center | 6 (7.1) |
| Multiple centers | |
| Number of tests studied | |
| 1 | 17 (20.2) |
| 2–5 | 5 (6.0) |
| >5 | 53 (63.1) |
| Unclear | 9 (10.7) |
| Reproducible intervention | |
| Yes | 44 (52.4) |
| No | 40 (47.6) |
| Sustainability assessed | |
| Yes | 14 (16.7) |
| No | 70 (83.3) |
| Data on clinical outcomes reported | |
| Yes | 45 (53.6) |
| No | 39 (46.4) |
Classification of interventions
| N (%) | |
|---|---|
| Studies in which a single intervention was performed | 46 (54.8) |
| Educational | 9 (10.7) |
| (C)POE | 33 (39.3) |
| Audit and feedback | 0 (0) |
| Others | 4 (4.8) |
| Studies in which combined interventions were performed | 38 (45.2) |
| Educational & audit and feedback | 15 (17.8) |
| Educational & (C)POE | 4 (4.8) |
| Educational & others | 3 (3.5) |
| Audit and feedback & (C)POE | 1 (1.2) |
| (C)POE & others | 2 (2.4) |
| Educational & (C)POE & Others | 4 (4.8) |
| Educational & audit and feedback & others | 4 (4.8) |
| Educational & audit and feedback & (C)POE | 3 (3.5) |
| Educational & audit and feedback & (C)POE & others | 2 (2.4) |
Abbreviation: (C)POE, (computerized) provider order entry.
Test volume reduction by category of intervention(s)
| Ref | Reduction in testing |
|---|---|
| Education | |
| [ | 8.7%* |
| [ | 32.7%† |
| [ | 22.4%‡ |
| [ | 27.8%* |
| [ | 14.7%§ |
| [ | 29.9%‡ |
| [ | 57%‡ |
| [ | 28.6% (I) vs 11.8% (C)∥ |
| [ | 40.6% (I) vs 21.3% (C)† |
| (C)POE | |
| Soft stop | |
| [ | 46% (pre-I) vs 14% (post-I)¶ |
| [ | 22.2–53.7% (I) vs 1.7–40.1% (C)∥ |
| [ | 16.7%‡ |
| [ | 21%‡ |
| [ | 39.8%‡ |
| [ | 19.5%‡ |
| [ | 73% (I) vs 49% (C)** |
| Hard stop | |
| [ | 11.2%†† |
| [ | 5.7%‡ |
| [ | 96.6%** |
| [ | 12.4% (I) vs 0.3% (C)‡‡ |
| [ | 0.56%‡ |
| Soft stop vs hard stop | |
| [ | 92.3% (I) vs 43.6% (C)‡ |
| Order form changes, display of fee | |
| [ | 44.2%† |
| [ | 3.9%† |
| [ | 25.5% (I) vs 1.3% (C)§§ |
| [ | 18.6%∥∥ |
| [ | 8.6% (I) vs 5.6% (C)* |
| [ | 17.3%‡‡ |
| [ | 56.5%‡ |
| [ | 54.3–52.5%+∥ |
| [ | 19.1% (I) vs 40.6%+ (C)‡‡ |
| [ | 18.5%∥ |
| [ | 32.7%‡‡ |
| [ | 4.5%¶¶ |
| [ | 23.9%‡ |
| Time limits on orders | |
| [ | 8.5%* |
| [ | 11.5%* |
| [ | 64.7%§ |
| Combined (C)POE & Others | |
| [ | 33.3–48.5%* |
| [ | 18.0%††† |
| [ | 13.7%‡ |
| [ | 55.2%† |
| Others | |
| [ | 38%‡ |
| [ | 12%‡ |
| [ | 15.9%‡ |
| [ | 3.6%† |
| Education & Audit/Feedback | |
| [ | 5.1–7.0%§ |
| [ | 25.5–42.2% (I) vs 3.7–22.4% (C)* |
| [ | 21%‡ |
| [ | 29.8%‡ |
| [ | 12.3–52.0% (I) vs 26.5–8.5%+ (C)‡‡ |
| [ | 14.6%* |
| [ | 12%‡‡‡ |
| [ | 48.6%‡ |
| [ | 38.0–73.7%* |
| [ | 20.8%* |
| [ | 13.5%* |
| [ | 4.5%+† |
| [ | 41.5% (I) vs 10.0%+ (C)* |
| [ | 24–32%* |
| [ | 14%† |
| Education & (C)POE | |
| [ | 26.7% and 36.0%‡ |
| [ | 61.5% and 100%‡‡ |
| [ | 3.1–58.5% (I) vs 4.1–33.9%+* |
| [ | 41.9% and 44.8%‡ |
| Education & Others | |
| [ | 20.7–56.3%* |
| [ | 7.5%* |
| [ | 69.5%‡ |
| Audit/Feedback & (C)POE | |
| [ | 17%* |
| (C)POE & Others | |
| [ | 33.3–60%* |
| [ | 47.2%+§§§ |
| Education, (C)POE & Others | |
| [ | 7.1–8.9%* |
| [ | 66%‡ |
| [ | 80.9% (I) vs 11.8% (C)‡ |
| [ | 34.5% (I) vs 10.1–14.8% (C)∥ |
| Education, Audit/Feedback & Others | |
| [ | 5.7–30.4% (I) vs 1.2–8.8%+ (C)§ |
| [ | 47.4%‡ |
| [ | 11.5%‡‡ |
| [ | 10.7% (I1) vs 52.3% (I2) vs 23.5% (I3)∥ |
| Education, Audit/Feedback & (C)POE | |
| [ | 20%‡ |
| [ | 95%∥∥∥ |
| [ | 19.0% (I) vs 7.6% (C)¶¶¶ |
| Education, Audit/Feedback, (C)POE & Others | |
| [ | 8%* |
| [ | 25.9%∥ |
*Number of target tests per (in)patient day; †Number of target tests per (in)patient; ‡Total number of target tests; §Number of tests per day; ∥Number of tests per admission, visit or discharge; ¶Percentage of admissions in which test was performed; **Percentage of redundant orders cancelled; ††Number of target tests per year; ‡‡Number of tests per month; §§Monthly tests per patient day; ∥∥Number of tests per 100 ED presentations; ¶¶Fewer tests in intervention group compared to control group; ***Number of tests per day; †††Number of tests per week per hospitalization; ‡‡‡Percentage of patients undergoing target test; §§§Number of tests per patient per visit; ∥∥∥Percentage reduction in use of panel; ¶¶¶Number of tests per 100 hospital days.
Abbreviations: Ref, reference; I, intervention group; C, control group; I1, intervention group 1; I2, intervention group 2; I3, intervention group 3.